Extra-Neural Metastases of Malignant Gliomas: Myth or Reality?
Malignant gliomas account for approximately 60% of all primary brain tumors in adults. Prognosis for these patients has not significantly changed in recent years—despite debulking surgery, radiotherapy and cytotoxic chemotherapy—with a median survival of 9–12 months. Virtually no patients are cured...
Main Author: | Patrick Beauchesne |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/1/461/ |
Similar Items
-
Extracranial Metastases of a Cerebral Glioblastoma: A Case Report and Review of the Literature
by: Jurij Rosen, et al.
Published: (2018-08-01) -
Extraneural metastatic gliosarcoma: A case report and review of the literature
by: Thara Tunthanathip, et al.
Published: (2020-01-01) -
Extraneural metastases in medulloblastoma
by: V M F Muoio, et al.
Published: (2011-01-01) -
A case of molecularly profiled extraneural medulloblastoma metastases in a child
by: Nahla Ali Mobark, et al.
Published: (2018-01-01) -
Evolution of radiotherapy and chemotherapy practice in malignant gliomas
by: Anusheel Munshi, et al.
Published: (2013-05-01)